Connecting clusters of patient to drug responses of cell lines to suggest personalized therapeutics for breast cancer

Simon Gordonov, Avi Ma'Ayan

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

Recent surge in genome-wide expression data from patient tumors and cell-lines in breast cancer, as well as response data of breast cancer cell-lines to many drugs, opens the opportunity for data integration approaches that can lead to better personalized therapeutics. Here we integrated such data to generate a tripartite network that connects clusters of patients to cell-lines, and cell-lines to drugs to suggest which drugs may work best for each cluster of patients. We combined gene expression profiles from 400 patient tumor samples from two independent publicly-available studies, with gene expression and drug growth-inhibition-response profiles of 31 breast cancer cell-lines to build this tripartite network.

Original languageEnglish
Title of host publicationProceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2012
Pages529-534
Number of pages6
DOIs
StatePublished - 2012
Event2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2012 - Philadelphia, PA, United States
Duration: 4 Oct 20127 Oct 2012

Publication series

NameProceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2012

Conference

Conference2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2012
Country/TerritoryUnited States
CityPhiladelphia, PA
Period4/10/127/10/12

Keywords

  • breast cancer
  • data integration
  • gene expression
  • molecular profiling
  • systems biology
  • systems pharmacology

Fingerprint

Dive into the research topics of 'Connecting clusters of patient to drug responses of cell lines to suggest personalized therapeutics for breast cancer'. Together they form a unique fingerprint.

Cite this